Literature DB >> 19770691

Early alterations of growth factor patterns in bronchoalveolar lavage fluid from preterm infants developing bronchopulmonary dysplasia.

Jasper V Been1, Anne Debeer, J Freek van Iwaarden, Nico Kloosterboer, Valéria Lima Passos, Gunnar Naulaers, Luc J Zimmermann.   

Abstract

UNLABELLED: Chronic lung disease of prematurity (bronchopulmonary dysplasia; BPD) is characterized by an arrest in lung development. We hypothesized that early alterations in pulmonary expression of growth factors important for normal lung development would precede development of BPD. Bronchoalveolar lavage fluid (BALF) was obtained from ventilated preterm infants (n = 62) on postnatal d 0, 1, 3, and 7 and analyzed for total phospholipids (PL), VEGF, PDGF-BB, TGF-alpha and -beta1, granulocyte macrophage colony stimulating factor (GM-CSF), and keratinocyte growth factor (KGF). Levels (Ln transformed) were compared between infants developing BPD and BPD-free survivors, adjusted for potential confounders. BPD was associated with higher overall GM-CSF (beta (95% CI) = 0.69 (0.13;1.25); p < 0.05), lower overall latent TGF-beta1 (beta (95% CI) = -1.19 (-1.87, -0.39); p < 0.01) and total PL (beta (95% CI) = -0.64 (-1.23, -0.05); p < 0.05), and lower d 0 and 3 levels of VEGF (mean difference (95% CI) = -1.75 (-2.72, -0.77), p < 0.001; and -1.18 (-2.30, -0.06), p < 0.05, respectively) and TGF-alpha (mean difference (95% CI) = -0.73 (-1.42, -0.04), p < 0.05; and -1.01 (-1.64, -0.38), p < 0.01, respectively). Day 0 VEGF levels had the highest predictive value for BPD (area under receiver operating characteristic curve = 0.87; p < 0.01). In conclusion, substantial alterations in BALF growth factor levels are present in infants developing BPD. An early imbalance in pulmonary growth factors may contribute to the developmental arrest of the lung seen in BPD. ABBREVIATIONS: :

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19770691     DOI: 10.1203/PDR.0b013e3181c13276

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  25 in total

Review 1.  Early biomarkers as predictors for bronchopulmonary dysplasia in preterm infants: a systematic review.

Authors:  Zhi-Qun Zhang; Xian-Mei Huang; Hui Lu
Journal:  Eur J Pediatr       Date:  2013-09-01       Impact factor: 3.183

2.  Transglutaminase 2: a new player in bronchopulmonary dysplasia?

Authors:  Thilo J Witsch; Gero Niess; Elpidoforos Sakkas; Tatyana Likhoshvay; Simone Becker; Susanne Herold; Konstantin Mayer; István Vadász; Jesse D Roberts; Werner Seeger; Rory E Morty
Journal:  Eur Respir J       Date:  2014-03-06       Impact factor: 16.671

3.  Quantification of amikacin in bronchial epithelial lining fluid in neonates.

Authors:  C Tayman; M N El-Attug; E Adams; A Van Schepdael; A Debeer; K Allegaert; A Smits
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

Review 4.  VEGF levels in humans and animal models with RDS and BPD: temporal relationships.

Authors:  Stephanie Meller; Vineet Bhandari
Journal:  Exp Lung Res       Date:  2012-03-06       Impact factor: 2.459

Review 5.  Aberrant signaling pathways of the lung mesenchyme and their contributions to the pathogenesis of bronchopulmonary dysplasia.

Authors:  Shawn K Ahlfeld; Simon J Conway
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-11-28

6.  Reduced platelet-derived growth factor receptor expression is a primary feature of human bronchopulmonary dysplasia.

Authors:  Antonia P Popova; J Kelley Bentley; Tracy X Cui; Michelle N Richardson; Marisa J Linn; Jing Lei; Qiang Chen; Adam M Goldsmith; Gloria S Pryhuber; Marc B Hershenson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-06-06       Impact factor: 5.464

Review 7.  The new bronchopulmonary dysplasia.

Authors:  Alan H Jobe
Journal:  Curr Opin Pediatr       Date:  2011-04       Impact factor: 2.856

8.  Deregulation of the lysyl hydroxylase matrix cross-linking system in experimental and clinical bronchopulmonary dysplasia.

Authors:  Thilo J Witsch; Pawel Turowski; Elpidoforos Sakkas; Gero Niess; Simone Becker; Susanne Herold; Konstantin Mayer; István Vadász; Jesse D Roberts; Werner Seeger; Rory E Morty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-27       Impact factor: 5.464

9.  Perinatal factors in neonatal and pediatric lung diseases.

Authors:  Rodney D Britt; Arij Faksh; Elizabeth Vogel; Richard J Martin; Christina M Pabelick; Y S Prakash
Journal:  Expert Rev Respir Med       Date:  2013-10-03       Impact factor: 3.772

10.  Bronchoalveolar lavage fluid from preterm infants with chorioamnionitis inhibits alveolar epithelial repair.

Authors:  Jasper V Been; Luc J I Zimmermann; Anne Debeer; Nico Kloosterboer; J Freek van Iwaarden
Journal:  Respir Res       Date:  2009-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.